nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.0126	0.0637	CbGeAlD
Xylometazoline—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00875	0.0444	CbGeAlD
Xylometazoline—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.00856	0.0434	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.00842	0.0427	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.00824	0.0418	CbGeAlD
Xylometazoline—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.00784	0.0398	CbGeAlD
Xylometazoline—ADRA1B—brain—acquired immunodeficiency syndrome	0.00669	0.0339	CbGeAlD
Xylometazoline—HTR1B—nervous system—acquired immunodeficiency syndrome	0.00661	0.0335	CbGeAlD
Xylometazoline—ADRA1D—brain—acquired immunodeficiency syndrome	0.00654	0.0332	CbGeAlD
Xylometazoline—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00643	0.0326	CbGeAlD
Xylometazoline—HTR1D—nervous system—acquired immunodeficiency syndrome	0.0064	0.0324	CbGeAlD
Xylometazoline—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.00636	0.0323	CbGeAlD
Xylometazoline—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.00616	0.0312	CbGeAlD
Xylometazoline—ADRA1A—blood—acquired immunodeficiency syndrome	0.00605	0.0307	CbGeAlD
Xylometazoline—ADRA2C—blood—acquired immunodeficiency syndrome	0.00577	0.0293	CbGeAlD
Xylometazoline—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.00556	0.0282	CbGeAlD
Xylometazoline—ADRA2C—vagina—acquired immunodeficiency syndrome	0.00535	0.0271	CbGeAlD
Xylometazoline—ADRA2C—lung—acquired immunodeficiency syndrome	0.00506	0.0256	CbGeAlD
Xylometazoline—HTR1B—brain—acquired immunodeficiency syndrome	0.00505	0.0256	CbGeAlD
Xylometazoline—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.00491	0.0249	CbGeAlD
Xylometazoline—HTR1D—brain—acquired immunodeficiency syndrome	0.00489	0.0248	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00473	0.024	CbGeAlD
Xylometazoline—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.00468	0.0238	CbGeAlD
Xylometazoline—ADRA2A—blood—acquired immunodeficiency syndrome	0.0046	0.0233	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.00451	0.0229	CbGeAlD
Xylometazoline—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00443	0.0225	CbGeAlD
Xylometazoline—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00427	0.0216	CbGeAlD
Xylometazoline—ADRA2A—lung—acquired immunodeficiency syndrome	0.00404	0.0205	CbGeAlD
Xylometazoline—ADRA1A—brain—acquired immunodeficiency syndrome	0.00376	0.0191	CbGeAlD
Xylometazoline—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.00374	0.019	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.0036	0.0182	CbGeAlD
Xylometazoline—ADRA2C—brain—acquired immunodeficiency syndrome	0.00358	0.0182	CbGeAlD
Xylometazoline—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.00346	0.0175	CbGeAlD
Xylometazoline—ADRA2A—brain—acquired immunodeficiency syndrome	0.00286	0.0145	CbGeAlD
Xylometazoline—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00276	0.014	CbGeAlD
Xylometazoline—HTR1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00128	0.0016	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00128	0.0016	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00128	0.0016	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00127	0.00158	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00127	0.00158	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00126	0.00157	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00126	0.00157	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00125	0.00155	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00124	0.00155	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00123	0.00153	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00121	0.00151	CbGpPWpGaD
Xylometazoline—ADRA2B—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.00121	0.0015	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.0012	0.0015	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0012	0.00149	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00119	0.00148	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00118	0.00147	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00118	0.00147	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00117	0.00146	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00117	0.00146	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00117	0.00145	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00117	0.00145	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00116	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00115	0.00143	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00114	0.00142	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00114	0.00142	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00114	0.00142	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00113	0.00141	CbGpPWpGaD
Xylometazoline—ADRA2C—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.00113	0.0014	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00112	0.0014	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00112	0.0014	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00112	0.0014	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00111	0.00138	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.0011	0.00137	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.0011	0.00137	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.0011	0.00137	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00109	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00106	0.00132	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00106	0.00132	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00106	0.00131	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00102	0.00126	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00101	0.00126	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00101	0.00126	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00101	0.00126	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000998	0.00124	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000998	0.00124	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000992	0.00124	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000992	0.00124	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00099	0.00123	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000986	0.00123	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000983	0.00122	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000977	0.00122	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000974	0.00121	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00097	0.00121	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000962	0.0012	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000959	0.00119	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000957	0.00119	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000947	0.00118	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000947	0.00118	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000942	0.00117	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000932	0.00116	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000932	0.00116	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000927	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000927	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000917	0.00114	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000915	0.00114	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000913	0.00114	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000912	0.00114	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000912	0.00114	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000901	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000901	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000895	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000893	0.00111	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000887	0.00111	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000881	0.0011	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00088	0.0011	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000874	0.00109	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000869	0.00108	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000865	0.00108	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000862	0.00107	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000862	0.00107	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000856	0.00107	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000856	0.00107	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000843	0.00105	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000842	0.00105	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000842	0.00105	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000836	0.00104	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000828	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000828	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000828	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000828	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000824	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00081	0.00101	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00081	0.00101	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00081	0.00101	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000804	0.001	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000803	0.001	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000801	0.000998	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000799	0.000996	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000793	0.000988	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000783	0.000975	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000783	0.000975	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000769	0.000958	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000769	0.000958	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000767	0.000955	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000759	0.000946	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000755	0.00094	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000753	0.000938	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000753	0.000938	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000753	0.000938	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000748	0.000932	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000748	0.000932	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000744	0.000926	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000736	0.000917	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000736	0.000917	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000733	0.000913	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000727	0.000906	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000718	0.000894	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000716	0.000892	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000705	0.000878	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000695	0.000866	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000695	0.000865	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000694	0.000865	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000694	0.000864	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000689	0.000858	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000689	0.000858	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000686	0.000854	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000684	0.000852	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000684	0.000852	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000684	0.000852	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000684	0.000852	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00068	0.000847	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000675	0.000841	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000675	0.00084	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000675	0.00084	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000666	0.00083	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00064	0.000798	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000635	0.000791	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000631	0.000786	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00063	0.000785	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000627	0.000781	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000626	0.00078	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000625	0.000779	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000622	0.000775	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000621	0.000773	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000618	0.000769	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000617	0.000768	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000607	0.000756	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000592	0.000737	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00059	0.000735	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00059	0.000735	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000585	0.000728	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000582	0.000725	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000581	0.000724	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000577	0.000719	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000576	0.000717	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000573	0.000714	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000568	0.000707	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000566	0.000705	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000564	0.000703	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00056	0.000697	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000555	0.000692	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000551	0.000687	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000532	0.000663	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000532	0.000663	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000529	0.000659	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000524	0.000653	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000521	0.000648	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00052	0.000648	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000516	0.000643	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000516	0.000643	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000513	0.000639	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000512	0.000638	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000511	0.000637	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000509	0.000634	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000506	0.00063	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000504	0.000628	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000498	0.00062	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000497	0.000619	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000497	0.000619	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000489	0.00061	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000489	0.00061	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000475	0.000592	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000472	0.000588	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000472	0.000588	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000469	0.000584	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000462	0.000576	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000462	0.000576	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000462	0.000575	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000452	0.000563	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000449	0.000559	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000442	0.00055	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000435	0.000542	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000435	0.000542	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000435	0.000542	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00043	0.000535	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000405	0.000504	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000404	0.000503	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000404	0.000503	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000404	0.000503	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000399	0.000497	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000395	0.000492	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000393	0.00049	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000378	0.000471	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000373	0.000464	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000372	0.000464	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000367	0.000457	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000367	0.000457	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000365	0.000454	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000361	0.00045	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000357	0.000445	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000341	0.000425	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000335	0.000418	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000333	0.000415	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000331	0.000412	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000328	0.000409	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000326	0.000406	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000321	0.0004	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000307	0.000383	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000303	0.000377	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000298	0.000371	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000298	0.000371	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000291	0.000363	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	0.00029	0.000362	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000277	0.000345	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000273	0.00034	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000271	0.000338	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000271	0.000337	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000267	0.000333	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000266	0.000331	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	0.000236	0.000294	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000234	0.000291	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000232	0.000289	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000211	0.000263	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00021	0.000261	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000197	0.000245	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000196	0.000244	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000194	0.000241	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000193	0.00024	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000172	0.000214	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000171	0.000213	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.00016	0.0002	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00016	0.000199	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000159	0.000198	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000157	0.000196	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000137	0.000171	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000124	0.000154	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000116	0.000144	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000114	0.000142	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000101	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.4e-05	0.000117	CbGpPWpGaD
